Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · IEX Real-Time Price · USD
3.380
-0.090 (-2.59%)
At close: Jul 2, 2024, 4:00 PM
3.460
+0.080 (2.37%)
After-hours: Jul 2, 2024, 6:04 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $899.20 million as of July 2, 2024. Its market cap has increased by 103.76% in one year.
Market Cap
899.20M
Enterprise Value
419.49M
1-Year Change
103.76%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $944.40M to $899.20M, a decrease of -4.79%. That is a compound annual growth rate of -0.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 923.10M | -17.62% |
| Dec 29, 2023 | 1.12B | 546.94% |
| Dec 30, 2022 | 173.20M | -54.23% |
| Dec 31, 2021 | 378.40M | -19.08% |
| Dec 31, 2020 | 467.60M | -21.25% |
| Dec 31, 2019 | 593.80M | -54.96% |
| Dec 31, 2018 | 1.32B | 39.60% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Owens & Minor | 996.02M |
| MiMedx Group | 988.95M |
| Cullinan Oncology | 964.22M |
| Tango Therapeutics | 961.61M |
| BioLife Solutions | 957.77M |
| Simulations Plus | 922.90M |
| Maravai LifeSciences Holdings | 921.85M |
| Liquidia | 920.02M |